Previous 10 | Next 10 |
Investment Thesis Abiomed 5-year share price performance. Source: TradingView The medical device industry has produced a number of notable share price winners in recent years, owing to advances in technology and the companies that have found ways to apply new technologies to augment or enh...
Abbot Laboratories (ABT), Penumbra (PEN), Align (ALGN), Bio-Rad (BIO), and ABIOMED (ABMD) are all steaming higher as doctor's and dentist's offices reopen. There is pent-up demand for these companies' products as people put off procedures due to the coronavirus. As the coronavirus began it...
Abiomed, Inc . (NASDAQ: ABMD) announced that on Thursday, August 6, 2020, the Company will release financial results for the first quarter of fiscal 2021. The Company will host a conference call to discuss the results on Thursday, August 6, 2020 at 8:00 a.m. ET. Michael R. Minogue, Chairman,...
The United States Food and Drug Administration (FDA) has approved one-way digital data streaming during patient support from Abiomed's (NASDAQ: ABMD) Automated Impella Controller (AIC), the external console used with Impella heart pumps . The data streaming capability is facilitated throug...
While economic uncertainty continues to be high, I want to invest in companies that are looking to solve today’s biggest problems. This leads me to a fast-growing player in healthcare: Abiomed Inc (NASDAQ: ABMD). Even at 14x revenue and 56x forward earnings, Abiomed is priced at a reaso...
Equity Financing Led by EW Healthcare Partners and Debt Financing Provided by Hayfin Capital Management EW Healthcare Partners Managing Director and Co-Founder Martin Sutter and Former Medtronic Chairman and CEO William Hawkins to Join MiMedx Board of Directors MARIETTA, Ga., July ...
The first published United States experience of patients who received Abiomed’s newest heart pump, Impella 5.5 with SmartAssist , finds 84% of the patients survived to explant with 76% native heart recovery. The study was published in the July edition of the American Society for Ar...
A few days ago, I published an article covering 10 Reasons Not To Buy A Stock . These reasons are mostly related to the quality of the underlying business and what should prompt you to approach an investment with caution. I couldn't help but notice that many investors in the comment section...
We don't have an analytical advantage, we just look in the right place. - Seth Klarman There has been much going on in the healthcare sector due to the impact of Covid-19. The sector has been one of the fastest to recover from the aftershocks of the pandemic. A glimpse of the Vanguard Heal...
Investment Thesis The investment thesis of this article is that a most important reason for investing in any stock is its potential for portfolio wealth-building, and that requires informed forecasts of its likely future price. Abiomed Inc. ( ABMD ) now scores less than at other times for ...
News, Short Squeeze, Breakout and More Instantly...
Abiomed (Nasdaq: ABMD) announces the United States Food and Drug Administration (FDA) has approved the version of Impella ECP that will be used in the Impella ECP Pivotal Trial, and the first two patients have been enrolled in the trial. Amir Kaki, MD, director of mechanical circulatory support...
Steel Dynamics Set to Join S&P 500; Super Micro Computer to Join S&P MidCap 400 Steel Dynamics Set to Join S&P 500; Super Micro Computer to Join S&P MidCap 400 PR Newswire NEW YORK , Dec. 19, 2022 /PRNewswire/ -- S&P MidCap 400 constituent...
Abiomed (Nasdaq: ABMD) announces the first three patients in the world have been treated with Impella RP Flex with SmartAssist, Abiomed’s newest heart pump for patients experiencing right heart failure. All three patients have now been successfully weaned off Impella support and two have...